Watch VideoThe maker of the COVID-19 drug remdesivir announced it's pricing its antiviral medication at $520 a dose for most U.S. patients.
On Monday, drug maker Gilead Sciences said that comes out to $3,120 for patients with private insurance for a "typical" five-day treatment course of six vials.
For the rest of the...
Gilead Sciences Announces Price Tag For Coronavirus Drug Remdesivir
Newsy
0 shares
1 views
You might like
Related news coverage
Virus-fighting drug's cost announced
WorldNews
Gilead Sciences said it will charge the U.S. government and other developed countries $390 per vial for its coronavirus-fighting..
Advertisement
More coverage
US stocks trade mixed as investors weigh reopening hopes against virus spread
Business Insider
· *US stocks traded mixed on Monday as investors continued to bet on economic reopenings despite soaring coronavirus case..